Pages that link to "Q40497236"
Jump to navigation
Jump to search
The following pages link to SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo (Q40497236):
Displaying 50 items.
- Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment (Q21142766) (← links)
- Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells (Q24315838) (← links)
- Parallel Aspects of the Microenvironment in Cancer and Autoimmune Disease (Q26753174) (← links)
- Implications of irradiating the subventricular zone stem cell niche (Q26765997) (← links)
- TGF-β/SMAD/GLI2 signaling axis in cancer progression and metastasis (Q27008239) (← links)
- Targeting TGF-β signaling in cancer (Q27012443) (← links)
- Targeting the Transforming Growth Factor-β Signaling in Cancer Therapy (Q27021750) (← links)
- Identification and In Vitro Expansion of Functional Antigen-Specific CD25 FoxP3 Regulatory T Cells in Hepatitis C Virus Infection (Q27485897) (← links)
- Role of TGFβ in regulation of the tumor microenvironment and drug delivery (review) (Q28081170) (← links)
- TGF-β signaling and its targeting for glioma treatment (Q28082042) (← links)
- SD-208, a novel protein kinase D inhibitor, blocks prostate cancer cell proliferation and tumor growth in vivo by inducing G2/M cell cycle arrest (Q28543910) (← links)
- Immunohistochemical localization of EGF, TGF-alpha, TGF-beta, and their receptors in rat corneas during healing of excimer laser ablation (Q28571648) (← links)
- Drug development against metastasis-related genes and their pathways: A rationale for cancer therapy (Q29010479) (← links)
- The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone (Q30299930) (← links)
- TGF-beta-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases (Q30429041) (← links)
- Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone (Q30439859) (← links)
- Small molecule antagonists of the TGF-beta1/TGF-beta receptor binding interaction (Q30483385) (← links)
- High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling (Q30665262) (← links)
- Combining cytotoxic and immune-mediated gene therapy to treat brain tumors (Q31013320) (← links)
- Mechanisms of induction of airway smooth muscle hyperplasia by transforming growth factor-beta (Q33283164) (← links)
- Conventional and experimental drug therapy in myelofibrosis with myeloid metaplasia (Q33389328) (← links)
- Therapeutic strategies for inhibiting invasion in glioblastoma (Q33426563) (← links)
- Targeting the transforming growth factor-beta signaling pathway in human cancer (Q33517772) (← links)
- Immunocompetent murine models for the study of glioblastoma immunotherapy (Q33574853) (← links)
- Controlling destiny through chemistry: small-molecule regulators of cell fate (Q33593482) (← links)
- The roles of TGFβ in the tumour microenvironment (Q33630845) (← links)
- Extracellular matrix molecules: potential targets in pharmacotherapy. (Q33694487) (← links)
- Peptide ligands that use a novel binding site to target both TGF-β receptors. (Q33708971) (← links)
- An orally active small molecule TGF-beta receptor I antagonist inhibits the growth of metastatic murine breast cancer (Q33812340) (← links)
- Evaluation of antitumor activity of a TGF-beta receptor I inhibitor (SD-208) on human colon adenocarcinoma. (Q33830588) (← links)
- Neuropilin-2 Expression Promotes TGF-β1-Mediated Epithelial to Mesenchymal Transition in Colorectal Cancer Cells (Q33957987) (← links)
- Triptolide inhibits proliferation and migration of colon cancer cells by inhibition of cell cycle regulators and cytokine receptors (Q34173719) (← links)
- Suppression of transforming growth factor-β effects in rabbit subconjunctival fibroblasts by activin receptor-like kinase 5 inhibitor (Q34208377) (← links)
- MicroRNA-584 and the protein phosphatase and actin regulator 1 (PHACTR1), a new signaling route through which transforming growth factor-β Mediates the migration and actin dynamics of breast cancer cells (Q34332277) (← links)
- Use of a TGFβ type I receptor inhibitor in mouse skin carcinogenesis reveals a dual role for TGFβ signaling in tumor promotion and progression (Q34363852) (← links)
- Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells (Q34477634) (← links)
- Efficient TGF-β/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression. (Q34516142) (← links)
- Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors. (Q34550440) (← links)
- Stable luciferase expression does not alter immunologic or in vivo growth properties of GL261 murine glioma cells (Q34645287) (← links)
- Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2. (Q34651528) (← links)
- Choosing between stem cell therapy and drugs in myelofibrosis (Q34734491) (← links)
- Trimodal Glioblastoma Treatment Consisting of Concurrent Radiotherapy, Temozolomide, and the Novel TGF-β Receptor I Kinase Inhibitor LY2109761 (Q35042985) (← links)
- Pharmacologic Inhibition of ALK5 Causes Selective Induction of Terminal Differentiation in Mouse Keratinocytes Expressing Oncogenic HRAS (Q35053451) (← links)
- Conversion of mechanical force into TGF-β-mediated biochemical signals. (Q35055426) (← links)
- Melanoma-initiating cells exploit M2 macrophage TGFβ and arginase pathway for survival and proliferation. (Q35067933) (← links)
- Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironment (Q35148340) (← links)
- Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer (Q35289038) (← links)
- Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers (Q35490960) (← links)
- Spontaneous bone metastases in a preclinical orthotopic model of invasive lobular carcinoma; the effect of pharmacological targeting TGFβ receptor I kinase. (Q35532495) (← links)
- Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma (Q35597405) (← links)